Sumitomo Pharma Co Ltd (STU:DPM)
€ 3.62 0.02 (0.56%) Market Cap: 1.47 Bil Enterprise Value: 3.14 Bil PE Ratio: 0 PB Ratio: 2.04 GF Score: 62/100

Sumitomo Dainippon Pharma Co Ltd ESG Briefing Transcript

Nov 27, 2019 / NTS GMT
Release Date Price: €17.2 (+0.58%)
Operator

Thank you very much for taking your time listening to our presentation this morning. This is Sumitomo Dainippon's second ESG meeting. We will give you the contents of our ESG initiatives, but we'd also like to address some of your questions at the end of this meeting. So your comments and feedback are highly appreciated.

This year, we invited 2 of our 3 outside directors; Dr. Atomi and Ms. Arai; in addition to Chairman, Mr. Tada; and President, Mr. Nomura.

Mr. Endo the other outside director, is not available today. First, Chairman Mr. Tada will make opening remarks, followed by 30-minute presentation from the President, Mr. Nomura, then we will ask 2 outside directors to talk about their views on Sumitomo Dainippon Pharma before opening the floor for Q&A.

Mr. Tada, the floor is yours.

Masayo Tada
Sumitomo Dainippon Pharma Co., Ltd. - Chairman

Ladies and gentlemen, good morning. I'm Tada, Chairman of the company. Once again, thank you very much for taking your time listening to our ESG presentation. Before we begin our presentation

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot